Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of liraglutide for weight management in pubertal adolescents with obesity
2014-004353-14Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity comparing liraglutide with placebo (2 arms). Primary endpoint: Change in BMI standard deviation score. Started Jul 2016; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on 2014-004353-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004353-14.